Document ID: chunk:federal_register_of_legislation:C2016A00078:clause:1_99
Version: federal_register_of_legislation:C2016A00078
Segment Type: clause
Provision Reference: sch 1 cl 99
Character Range: 34490–35610

99  Schedule 3 (Chapter 30, at the end of the Notes)
Add:

Subheading Notes.
 1.‑ For the purposes of 3002.13 and 3002.14, the following are to be treated:
 (a) as unmixed products, pure products, whether or not containing impurities;
 (b) as products which have been mixed:
 (1) the products mentioned in (a) above dissolved in water or in other solvents; and
 (2) the products mentioned in (a) and (b)(1) above with an added stabiliser necessary for their preservation or transport; and
 (3) the products mentioned in paragraph (a) and (b)(1) and (b)(2) above with any other additive.
 2.‑ 3003.60 and 3004.60 cover medicaments containing artemisinin (INN) for oral ingestion combined with other pharmaceutical active ingredients, or containing any of the following active principles, whether or not combined with other pharmaceutical active ingredients: amodiaquine (INN); artelinic acid or its salts; artenimol (INN); artemotil (INN); artemether (INN); artesunate (INN); chloroquine (INN); dihydroartemisinin (INN); lumefantrine (INN); mefloquine (INN); piperaquine (INN); pyrimethamine (INN) or sulfadoxine (INN).